Oxidative Medicine and Cellular Longevity / 2019 / Article / Fig 5

Research Article

New C-Terminal Conserved Regions of Tafazzin, a Catalyst of Cardiolipin Remodeling

Figure 5

Distribution of mammalian tafazzins over lifespan and body weight (a, b) or longevity quotient (c, d) for classic tafazzin (CT) and unconventional T1 and T2 ones (a, c) or E5, T1, and T2 tafazzins (b, d).
(a)
(b)
(c)
(d)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.